HOPE In Practice: Lessons From the Field [Free Webinar]
The care-at-home industry is navigating a significant regulatory shift.
On May 13, 2026, the Centers for Medicare & Medicaid Services announced a six-month, nationwide moratorium on new Medicare enrollment for hospice providers and home health agencies—the most sweeping fraud prevention action CMS has taken in the agency's history.
The moratorium temporarily halts new provider enrollment in these high-risk categories while CMS intensifies targeted investigations, deploys advanced data analytics, and accelerates removal of providers suspected of fraud. Importantly, the moratorium will not impact current enrollments; existing providers can continue delivering services to Medicare beneficiaries.
The action also closes a common loophole: the nationwide approach eliminates the ability of bad actors to evade detection by shifting operations across state lines and applies to all applications for initial Medicare enrollment and certain changes in majority ownership—strategies frequently used to obscure control by bad actors.
The scale of enforcement already underway is significant. CMS has suspended payments to 773 hospices and 23 home health agencies suspected of fraud in Los Angeles alone, representing $70 million in suspended funds. Across the country, CMS has been revoking or deactivating hundreds of providers, conducting nationwide hospice site visits, and launching a new publicly available hospice scoring system to increase transparency and flag providers with troubling patterns of utilization, quality, or compliance.
For providers operating with integrity, this moment calls for a clear-eyed look at compliance posture. Heightened federal scrutiny means that documentation quality, billing accuracy, and operational transparency are front-line business priorities. Agencies with documentation gaps, inconsistent clinical records, or unclear operational structures face real exposure, even without any intent to defraud.
The moratorium also sends a broader signal: the regulatory environment for care at home is tightening, and agencies that aren't proactively managing compliance will find themselves in reactive mode when they can least afford it.
Maxwell TEC works with hospice and home health agencies that are committed to doing things right—and this regulatory environment is exactly where that partnership matters most.
On the consulting side, Maxwell TEC's strategic advisors help agencies assess their current compliance infrastructure, identify vulnerabilities in documentation and billing, and build operational processes that withstand scrutiny. Whether an agency is preparing for a site visit, conducting an internal compliance review, or working to strengthen its quality reporting, Maxwell TEC brings the care-at-home expertise to guide that work.
On the technology side, Maxwell TEC's solutions support the kind of clinical documentation, communication, and data integrity that regulators are increasingly focused on. Tools like nanaCONNECT help agencies maintain accurate, timely patient communication records, while Maxwell TEC's analytics capabilities give leadership visibility into utilization patterns and outcomes—the same data points CMS is now scrutinizing at the federal level.
The agencies that will succeed amid this period of heightened oversight are those that treat compliance as an operational value, not an afterthought. Maxwell TEC is built to support exactly that.
The window to get ahead of this is now. Maxwell TEC works with hospice and home health agencies to close compliance gaps, build documentation integrity, and implement technology that supports transparency at every level of operations—before scrutiny finds the cracks. Reach out to our experts at sales@maxwelltec.com, or visit www.maxwelltec.com to learn how we can help your agency stay ahead of what's coming.